Nuveen Asset Management, LLC Verve Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,315,771 shares of VERV stock, worth $14.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,315,771

Previous 1,671,724 21.29%

Holding current value

$14.6 Million

Previous $8.09 Million 8.29%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.5 - $7.19 $1.6 Million - $2.56 Million	-355,953 Reduced 21.29%	1,315,771 $7.42 Million
Q3 2024 Nov 14, 2024	BUY	$4.4 - $7.86 $3.79 Million - $6.77 Million	861,227 Added 106.26%	1,671,724 $8.09 Million
Q2 2024 Aug 09, 2024	SELL	$4.76 - $12.79 $308,076 - $827,794	-64,722 Reduced 7.39%	810,497 $3.96 Million
Q1 2024 May 13, 2024	BUY	$10.81 - $17.96 $4.51 Million - $7.49 Million	416,971 Added 90.99%	875,219 $11.6 Million
Q4 2023 Feb 14, 2024	BUY	$8.84 - $18.7 $2.47 Million - $5.23 Million	279,604 Added 156.51%	458,248 $6.39 Million

Q3 2023 Nov 14, 2023	BUY	$11.42 - $20.82 $31,290 - $57,046	2,740 Added 1.56%	178,644 $2.37 Million
Q2 2023 Aug 14, 2023	BUY	$13.34 - $19.9 $202,501 - $302,082	15,180 Added 9.44%	175,904 $3.3 Million
Q1 2023 May 15, 2023	SELL	$14.3 - $24.01 $396,825 - $666,277	-27,750 Reduced 14.72%	160,724 $2.32 Million
Q4 2022 Feb 14, 2023	SELL	$17.85 - $40.7 $1.96 Million - $4.47 Million	-109,910 Reduced 36.84%	188,474 $3.65 Million
Q3 2022 Nov 14, 2022	BUY	$15.63 - $41.49 $2.33 Million - $6.18 Million	148,964 Added 99.69%	298,384 $10.3 Million
Q2 2022 Aug 15, 2022	BUY	$11.14 - $23.17 $188,032 - $391,086	16,879 Added 12.73%	149,420 $2.28 Million
Q1 2022 May 16, 2022	BUY	$20.92 - $39.36 $1.6 Million - $3.02 Million	76,644 Added 137.12%	132,541 $2.91 Million
Q4 2021 Feb 14, 2022	SELL	$31.94 - $54.82 $130,954 - $224,762	-4,100 Reduced 6.83%	55,897 $1.83 Million
Q3 2021 Nov 12, 2021	BUY	$46.0 - $73.99 $2.76 Million - $4.44 Million	59,997 New	59,997 $2.82 Million

Others Institutions Holding VERV

# of Institutions

Shares Held

8.51M

Call Options Held

2.9K

Put Options Held

37.1K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $667M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Verve Therapeutics, Inc. Transaction History